Differential endocytosis of fluorescein iso-thiocyanate-concanavalin A by normal and chronic myeloid leukemic granulocytes. 1987

S M Zingde, and P N Anklesaria, and S H Advani, and A N Bhisey, and B P Gothoskar

Isolated granulocytes from normal individuals and patients suffering from chronic myeloid leukemia (CML) displayed different fluorescent patterns on treatment with fluorescein isothiocyanate concanavalin A (Fl-Con A). The ligand was internalized by 86% of the normal granulocytes, while 80% of the leukemic granulocytes exhibited Fl-Con A localized on the cell periphery. In further experiments, pretreatment of the normal granulocytes with cytochalasin B, iodoacetamide, 2-deoxyglucose and sodium fluoride (but not with sodium azide or dinitrophenol) was found to drastically inhibit internalization of the ligand. However, pretreatment of granulocytes from CML patients with cytochalasin B and 2-deoxyglucose, caused only a little alteration in the pattern of Fl-Con A labelling relative to untreated cells. These results indicate that CML granulocytes are defective in their ability to endocytose Fl-Con A. We suggest that this differential interaction between Fl-Con A and normal and leukemic granulocytes is a convenient system to study the initial steps in receptor mediated endocytosis of Concanavalin A.

UI MeSH Term Description Entries
D007460 Iodoacetamide An alkylating sulfhydryl reagent. Its actions are similar to those of iodoacetate.
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D003078 Colchicine A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE). Colchicine, (+-)-Isomer,Colchicine, (R)-Isomer
D003208 Concanavalin A A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.
D003571 Cytochalasin B A cytotoxic member of the CYTOCHALASINS. Phomin
D004705 Endocytosis Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. ENDOSOMES play a central role in endocytosis. Endocytoses
D005452 Fluoresceins A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays. Tetraiodofluorescein

Related Publications

S M Zingde, and P N Anklesaria, and S H Advani, and A N Bhisey, and B P Gothoskar
January 1980, Acta haematologica,
S M Zingde, and P N Anklesaria, and S H Advani, and A N Bhisey, and B P Gothoskar
January 1992, Leukemia research,
S M Zingde, and P N Anklesaria, and S H Advani, and A N Bhisey, and B P Gothoskar
August 1985, Biochemical medicine,
S M Zingde, and P N Anklesaria, and S H Advani, and A N Bhisey, and B P Gothoskar
December 1994, Leukemia research,
S M Zingde, and P N Anklesaria, and S H Advani, and A N Bhisey, and B P Gothoskar
October 1992, Annals of hematology,
S M Zingde, and P N Anklesaria, and S H Advani, and A N Bhisey, and B P Gothoskar
May 1989, Cancer biochemistry biophysics,
S M Zingde, and P N Anklesaria, and S H Advani, and A N Bhisey, and B P Gothoskar
February 1973, Proceedings of the National Academy of Sciences of the United States of America,
S M Zingde, and P N Anklesaria, and S H Advani, and A N Bhisey, and B P Gothoskar
September 1996, Leukemia research,
S M Zingde, and P N Anklesaria, and S H Advani, and A N Bhisey, and B P Gothoskar
February 1985, Cancer biochemistry biophysics,
Copied contents to your clipboard!